Although there is a lack of specialized research on the direct impact of TMAO on IBD through the PERK pathway, considering TMAO’s ERS inducing ability and the critical role of the PERK pathway in IBD, the relationship between the two deserves further in-depth investigation. Here, EIF2AK3 is linked to inflammatory bowel disease.